CCR6 and Arthritis: An arthritis-induced study model of CCR6−/− mice had not exhibited any clinical signs consistent with disease compared to WT controls, but revealed that CD4+ T cells, TH17 cells and CD25 FoxP3+ regulatory T cells showed up-regulation of CCR6 with RANKL, which contributed towards disease, particularly osteoclastogenesis.